United Therapeutics (UTHR) Insider Trading & Ownership $283.46 -0.85 (-0.30%) As of 11:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)11Amount OfInsider Selling(Last 12 Months)$148.85 M Get UTHR Insider Trade Alerts Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address UTHR Insider Buying and Selling by Quarter Remove Ads United Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/7/2025Raymond DwekDirectorSell4,000$284.55$1,138,200.00 4/3/2025Paul A MahonEVPSell11,000$306.18$3,367,980.00 3/24/2025Tommy G ThompsonDirectorSell2,500$318.80$797,000.00 2/24/2025Michael BenkowitzCOOSell10,000$360.76$3,607,600.00 2/18/2025Michael BenkowitzCOOSell10,000$371.05$3,710,500.00 2/10/2025Michael BenkowitzCOOSell10,000$348.06$3,480,600.00 2/3/2025Michael BenkowitzCOOSell10,000$353.64$3,536,400.00 1/27/2025Michael BenkowitzCOOSell10,000$370.71$3,707,100.00 1/21/2025Michael BenkowitzCOOSell10,000$364.91$3,649,100.00 1/13/2025Michael BenkowitzCOOSell10,000$364.62$3,646,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/30/2024Michael BenkowitzCOOSell10,000$356.68$3,566,800.00 12/30/2024Nilda MesaDirectorSell255$355.77$90,721.35 12/23/2024Michael BenkowitzCOOSell10,000$361.95$3,619,500.00 12/18/2024Louis W SullivanDirectorSell26,209$373.22$9,781,722.98 12/5/2024Paul A MahonEVPSell7,700$374.37$2,882,649.00 11/25/2024Michael BenkowitzCOOSell10,000$372.75$3,727,500.00 11/21/2024Paul A MahonEVPSell7,700$367.36$2,828,672.00 11/11/2024Judy D OlianDirectorSell1,750$412.48$721,840.00 11/11/2024Michael BenkowitzCOOSell15,000$407.32$6,109,800.00 11/8/2024Nilda MesaDirectorSell224$412.28$92,350.72 11/7/2024Michael BenkowitzCOOSell15,000$401.44$6,021,600.00 11/1/2024Christopher CauseyDirectorSell510$376.63$192,081.30 11/1/2024Michael BenkowitzCOOSell14,700$374.46$5,504,562.00 10/28/2024James EdgemondCFOSell7,800$350.00$2,730,000.00 10/21/2024James EdgemondCFOSell7,782$366.99$2,855,916.18 10/14/2024James EdgemondCFOSell7,792$355.88$2,773,016.96 10/7/2024James EdgemondCFOSell7,794$355.54$2,771,078.76 9/30/2024James EdgemondCFOSell7,792$358.62$2,794,367.04 9/23/2024James EdgemondCFOSell7,796$354.04$2,760,095.84 9/9/2024James EdgemondCFOSell7,802$345.41$2,694,888.82 9/3/2024James EdgemondCFOSell7,785$362.37$2,821,050.45 8/26/2024Martine A RothblattCEOSell269$348.41$93,722.29 8/19/2024Martine A RothblattCEOSell3,600$344.18$1,239,048.00 8/8/2024Martine A RothblattCEOSell3,600$328.39$1,182,204.00 8/7/2024Michael BenkowitzCOOSell25,000$323.38$8,084,500.00 8/6/2024Martine A RothblattCEOSell3,600$325.45$1,171,620.00 8/2/2024Martine A RothblattCEOSell3,600$324.73$1,169,028.00 8/2/2024Raymond DwekDirectorSell5,000$325.35$1,626,750.00 7/30/2024Martine A RothblattCEOSell3,600$337.40$1,214,640.00 7/26/2024Martine A RothblattCEOSell3,600$338.61$1,218,996.00 Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma7/24/2024Martine A RothblattCEOSell3,600$334.00$1,202,400.00 7/22/2024Martine A RothblattCEOSell3,600$331.32$1,192,752.00 7/18/2024Martine A RothblattCEOSell3,600$331.79$1,194,444.00 7/16/2024Martine A RothblattCEOSell3,600$328.03$1,180,908.00 7/12/2024Martine A RothblattCEOSell3,600$324.97$1,169,892.00 7/10/2024Martine A RothblattCEOSell3,600$326.35$1,174,860.00 7/8/2024Martine A RothblattCEOSell3,600$317.05$1,141,380.00 7/5/2024Martine A RothblattCEOSell3,600$313.25$1,127,700.00 7/3/2024Martine A RothblattCEOSell3,600$312.48$1,124,928.00 7/1/2024Martine A RothblattCEOSell3,600$320.45$1,153,620.00 6/27/2024Martine A RothblattCEOSell3,600$316.62$1,139,832.00 6/25/2024Nilda MesaDirectorSell266$318.58$84,742.28 6/24/2024Martine A RothblattCEOSell3,600$315.97$1,137,492.00 6/21/2024Martine A RothblattCEOSell3,600$313.91$1,130,076.00 6/14/2024Martine A RothblattCEOSell3,600$287.22$1,033,992.00 6/13/2024Christopher CauseyDirectorSell2,000$281.53$563,060.00 6/12/2024Martine A RothblattCEOSell3,600$281.19$1,012,284.00 6/10/2024Martine A RothblattCEOSell3,600$273.95$986,220.00 6/7/2024Martine A RothblattCEOSell3,600$277.13$997,668.00 5/31/2024Martine A RothblattCEOSell3,600$272.48$980,928.00 5/28/2024Martine A RothblattDirectorSell3,600$269.06$968,616.00 5/23/2024Martine A RothblattDirectorSell3,600$275.78$992,808.00 5/21/2024Martine A RothblattDirectorSell1,468$275.85$404,947.80 5/16/2024Martine A RothblattDirectorSell3,600$272.37$980,532.00 5/14/2024Christopher PatuskyDirectorSell1,310$264.35$346,298.50 5/13/2024Martine A RothblattCEOSell3,600$265.48$955,728.00 5/9/2024Martine A RothblattCEOSell3,600$264.22$951,192.00 5/6/2024Martine A RothblattCEOSell3,600$259.70$934,920.00 5/3/2024Christopher CauseyDirectorSell2,240$259.91$582,198.40 5/2/2024Martine A RothblattCEOSell3,600$258.09$929,124.00 4/30/2024Martine A RothblattCEOSell3,600$235.35$847,260.00 4/26/2024Martine A RothblattCEOSell3,600$235.20$846,720.00 4/24/2024Martine A RothblattCEOSell3,600$238.81$859,716.00 4/22/2024Martine A RothblattCEOSell3,600$236.47$851,292.00 4/18/2024Martine A RothblattCEOSell3,600$237.91$856,476.00 4/16/2024Martine A RothblattCEOSell3,600$232.05$835,380.00 (Data available from 1/1/2013 forward) UTHR Insider Trading Activity - Frequently Asked Questions Who is on United Therapeutics's Insider Roster? The list of insiders at United Therapeutics includes Christopher Causey, Christopher Patusky, James Edgemond, Judy D Olian, Louis W Sullivan, Martine A Rothblatt, Michael Benkowitz, Nilda Mesa, Paul A Mahon, Raymond Dwek, and Tommy G Thompson. Learn more on insiders at UTHR. What percentage of United Therapeutics stock is owned by insiders? 11.90% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings. Which United Therapeutics insiders have been buying company stock? The following insider purchased UTHR shares in the last 24 months: Christopher Patusky ($684.36). How much insider buying is happening at United Therapeutics? Insiders have purchased a total of 6 UTHR shares in the last 24 months for a total of $684.36 bought. Which United Therapeutics insiders have been selling company stock? The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($2,086,379.70), Christopher Patusky ($722,618.50), James Edgemond ($22,200,414.05), Judy D Olian ($721,840.00), Louis W Sullivan ($9,781,722.98), Martine A Rothblatt ($75,379,917.79), Michael Benkowitz ($61,971,762.00), Nilda Mesa ($658,766.67), Paul A Mahon ($36,550,076.00), Raymond Dwek ($2,764,950.00), and Tommy G Thompson ($797,000.00). How much insider selling is happening at United Therapeutics? Insiders have sold a total of 721,096 United Therapeutics shares in the last 24 months for a total of $213,635,447.69 sold. United Therapeutics Key ExecutivesDr. Martine A. Rothblatt J.D. (Age 69)M.B.A., Ph.D., Founder, Chairman & CEO Compensation: $5.66MMr. Michael I. Benkowitz (Age 52)President & COO Compensation: $3.26M13 recent tradesMr. James C. Edgemond (Age 56)CFO & Treasurer Compensation: $2.15M2 recent tradesMr. Paul A. Mahon J.D. (Age 60)Executive VP, General Counsel & Corporate Secretary Compensation: $2.44M3 recent tradesMr. Dewey Steadman C.F.A.Head of Investor RelationsMs. Holly HobsonAssociate Vice President of Human ResourcesKevin T. GraySenior Vice President of Strategic Operations & LogisticsMr. Patrick Poisson (Age 56)Executive VP of Technical Operations Dr. Leigh PetersonExecutive Vice President of Product Development & XenotransplantationMr. Gil GoldenSenior VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ALNY Insider Selling BIIB Insider Selling INCY Insider Selling BMRN Insider Selling EXEL Insider Selling NBIX Insider Selling EXAS Insider Selling HALO Insider Selling MDGL Insider Selling RGEN Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market This page (NASDAQ:UTHR) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTHR Stock Free UTHR Stock Alerts